Earnings Call · Q4 FY2022·2023-02-16

Q4 22EPS +28.26%·Rev n/aQ3 22EPS -4.25%·Rev n/aQ2 22EPS +11.76%·Rev n/aQ1 22EPS +8.49%·Rev n/a⚠ consensus missing

WEST PHARMACEUTICAL SERVICES INC WST

Quintin Lai — Vice President, Investor Relations

Eric Green — President and Chief Executive Officer

Bernard Birkett — Chief Financial Officer

+14.5%1d on move date+15.9% vs SPY3d+9.9%5d+11.8%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more WST calls or request research access.

More WST calls Browse calls Request research access